"FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss"
Both medications are approved by the UKs Medicines and Healthcare products Regulatory Agency (MHRA) for treating: Obesity (BMI 30 or above), or Overweight (BMI 27 or above) with at least one weight-related health condition Wegovy, manufactured by Novo Nordisk, contains semaglutide
Now, lets go deeper as I would explain to any of my in-home patients
To mitigate this, many doctors begin with a lower dose of GLP-1 and gradually increase it, which can help the body adjust and reduce side effects, says Salhab
The frequency of IV or injection therapy depends on your wellness goals, lifestyle, and medical history
This helps reduce hunger and increase feelings of fullness, making it easier to follow a low-calorie diet